European Stocks to Watch: ABB Ltd (ADR) (ABB), Novo Nordisk A/S (ADR) (NVO)

0
115

ABB Ltd (ADR) (NYSE:ABB):

Stock’s Trading Stats:

ABB Ltd (ADR) (NYSE:ABB) surged 1.04% yesterday and closed at $20.00. The company’s market capitalization is at $46.50 billion with an average trading volume of 1.59 Million. The total number of Outstanding Shares Held by the company are 2.19 billion.

Recent Press Release:

ABB Ltd. (ABB) provides power and automation technologies for utility and industrial customers worldwide. The company’s Discrete Automation and Motion segment provides motors, generators, variable speed drives, programmable logic controllers, robots and robotics, solar inverters, wind converters, rectifiers, and excitation systems, in addition to power quality and protection solutions, electric vehicle fast charging infrastructure solutions, components and subsystems for railways, and related services for discrete automation, process industries, transportation, and utilities. Its Low Voltage Products segment provides protection, control, and measurement for electrical installations; enclosures, switchboards, electronics, and electromechanical devices for industrial machines and plants; products for wiring and cable administration, cable protection systems, power connection, and safety; and building control systems for home and building automation. The company’s Process Automation segment develops and sells control and plant optimization systems, automation products and solutions, and industry-specific application services for the oil, gas, petrochemicals, metals and minerals, marine and turbocharging, pulp and paper, chemical and pharmaceuticals, and power industries. Its Power Products segment offers circuit breakers, switchgears, and capacitors, in addition to instrument, power, distribution, and traction transformers for electrical and other infrastructure utilities, in addition to industrial and commercial customers. The company’s Power Systems segment provides transmission and distribution systems, in addition to power plant automation and electrification solutions, counting monitoring and control products, software and services, and components for power generation, transmission and distribution utilities, and other infrastructure utilities, in addition to other industrial and commercial enterprises. ABB Ltd was founded in 1883 and is headquartered in Zurich, Switzerland.

Novo Nordisk A/S (ADR) (NYSE:NVO):

Stock’s Trading Stats:

Novo Nordisk A/S (ADR) (NYSE:NVO) closed at $56.62 yesterday by showing an increase of 0.87%. The total number of outstanding shares held by the company are 2.06 billion with the total market capitalization of $116.68 billion. The number of shares traded on the last trading session are 1.34 Million.

Recent Press Release:

Novo Nordisk A/S (NVO) on March 29, 2016 stated financial results for the fourth quarter and full fiscal year ended December 31, 2015, and offered an overview of corporate accomplishments and plans.

Emisphere stated a net loss of $10.1 million, or ($0.18) per basic and diluted share, for the quarter ended December 31, 2015, contrast to net income of $0.4 million, or $0.01 per basic and diluted share, for the quarter ended December 31, 2014.

The Company stated an operating loss of $4.2 million for the fourth quarter 2015, contrast to an operating loss of $3.3 million for the same period in 2014.

Total operating expenses were $3.6 million for the fourth quarter 2015, an enhance of $0.3 million or 9.9% contrast to the same period in 2014. Total operating expenses comprise research and development costs of $0.1 million contrast to $0.2 million in 2014, and selling, general and administrative expenses of $3.5 million, an enhance of $0.5 million or 16.7% contrast to the same period in 2014. Other expense for the fourth quarter of 2015 was $6.5 million contrast to other expense of $3.4 million for the fourth quarter of 2014.

Total operating expenses were $17.6 million for the year ended December 31, 2015, contrast to $9.3 million for the year ended December 31, 2014, an enhance of $8.3 million or 89.3%. Total operating expenses comprise research and development costs of $0.5 million (a decrease of $0.7 million or 57.9% contrast to 2014), and selling, general and administrative expenses of $17.1 million (an enhance of $9.0 million or 110% contrast to 2014).